Apogree Therapeutics Shares Are Trading Higher After the Company Announced Its Initiated Dosing of Its Clinical Trail for APG990.
Apogree Therapeutics Shares Are Trading Higher After the Company Announced Its Initiated Dosing of Its Clinical Trail for APG990.
Apogee Therapeutics的股票在公司宣佈已開始APG990臨床試驗的劑量投放後上漲。
Apogree Therapeutics Shares Are Trading Higher After the Company Announced Its Initiated Dosing of Its Clinical Trail for APG990.
Apogee Therapeutics的股票在公司宣佈已開始APG990臨床試驗的劑量投放後上漲。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間